Abraham Rubinstein

Title: Abraham Rubinstein: Innovator in Controlled Release Drug Delivery Systems

Introduction

Abraham Rubinstein is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of drug delivery systems, holding a total of 4 patents. His work focuses on enhancing the efficacy of oral drug delivery through innovative technologies.

Latest Patents

Rubinstein's latest patents include advancements in controlled release oral drug delivery systems. One of his inventions relates to a synchronous drug delivery composition that comprises a polymeric matrix made of hydrogel blended with a hydrophobic polymer. This erodible matrix allows for the synchronous release of the drug, hydrogel, and agents that enhance intestinal drug absorption or inhibit intestinal drug degradation. Another patent describes a controlled release drug delivery system that utilizes a polymeric matrix which erodes in the gastrointestinal tract. This system is designed for drugs susceptible to enzymatic degradation, ensuring that the drug is effectively absorbed across the intestinal mucosal tissues.

Career Highlights

Throughout his career, Rubinstein has worked with prominent organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Perio Products Ltd. His innovative approaches have positioned him as a key figure in the development of advanced drug delivery technologies.

Collaborations

Rubinstein has collaborated with notable professionals in his field, including Michael M. Friedman and Boaz Tirosh. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Abraham Rubinstein's contributions to controlled release drug delivery systems highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to enhancing drug efficacy and patient outcomes.